Nancey buys SPNC 27.43: Spectranetics (SPNC) Receives FDA 510(k) Clearance for ISR Products
Spectranetics (Nasdaq: SPNC) announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance of their peripheral atherectomy products, Turbo-Tandem® and Turbo Elite®, for the treatment of in-stent restenosis (ISR). The clearance prompts a . ... ...
30 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home